Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

SHE:002550 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	9,798	7,749	7,525	8,012	6,181	5,439
Market Cap Growth	26.86%	2.97%	-6.07%	29.61%	13.64%	-7.21%
Enterprise Value	8,757	7,071	7,054	7,508	5,582	4,818
Last Close Price	7.84	6.09	5.66	5.90	4.45	3.80
PE Ratio	23.16	21.76	41.38	24.77	34.14	-
Forward PE	21.78	20.00	20.00	20.00	20.00	20.00
PS Ratio	6.39	5.08	4.15	3.48	3.30	3.26
PB Ratio	3.55	3.08	3.04	3.29	2.92	2.63
P/TBV Ratio	3.72	3.23	3.23	3.43	3.08	2.78
P/FCF Ratio	43.87	18.27	17.38	-	468.80	21.35
P/OCF Ratio	27.58	15.06	14.11	-	59.69	17.14
EV/Sales Ratio	5.71	4.63	3.89	3.26	2.98	2.89
EV/EBITDA Ratio	20.43	20.39	30.49	26.13	25.17	17.19
EV/EBIT Ratio	23.82	25.06	43.50	33.74	36.63	22.94
EV/FCF Ratio	39.21	16.68	16.29	-	423.36	18.91
Debt / Equity Ratio	-	0.01	0.02	0.04	0.04	0.02
Debt / EBITDA Ratio	-	0.06	0.24	0.36	0.42	0.15
Debt / FCF Ratio	-	0.05	0.13	-	7.10	0.16
Asset Turnover	0.53	0.55	0.65	0.87	0.76	0.62
Inventory Turnover	1.69	1.35	1.84	3.03	2.92	3.13
Quick Ratio	8.26	5.39	4.89	4.00	3.83	4.18
Current Ratio	11.84	7.58	7.90	6.07	5.30	5.35
Return on Equity (ROE)	15.36%	13.35%	7.28%	14.06%	8.91%	-6.71%
Return on Assets (ROA)	7.95%	6.30%	3.64%	5.24%	3.84%	4.87%
Return on Invested Capital (ROIC)	18.31%	13.77%	7.34%	11.02%	9.41%	13.26%
Return on Capital Employed (ROCE)	12.90%	10.80%	6.30%	8.80%	6.90%	9.70%
Earnings Yield	4.39%	4.59%	2.42%	4.04%	2.93%	-2.43%
FCF Yield	2.28%	5.47%	5.75%	-1.78%	0.21%	4.68%
Dividend Yield	1.56%	1.97%	2.12%	2.04%	2.70%	3.16%
Payout Ratio	35.05%	42.56%	87.31%	47.98%	83.67%	-
Buyback Yield / Dilution	0.89%	2.11%	-0.41%	-7.16%	-0.58%	4.01%
Total Shareholder Return	2.40%	4.08%	1.71%	-5.13%	2.11%	7.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.